Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Juhyun | - |
dc.contributor.author | Noh, A. Long Sae Mi | - |
dc.contributor.author | Zheng, Ting | - |
dc.contributor.author | Kang, Ju-hee | - |
dc.contributor.author | Yim, Mijung | - |
dc.date.available | 2021-02-22T11:32:04Z | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 0014-4827 | - |
dc.identifier.issn | 1090-2422 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/10157 | - |
dc.description.abstract | Osteoclasts are responsible for bone erosion in diseases such as osteoporosis and rheumatoid arthritis. In the present study, we investigate the effects of eriodictyol, a flavonoid found naturally in citrus fruits, on the receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclast formation using mouse bone marrow macrophages (BMMs). Eriodictyol inhibited RANKL-induced osteoclast formation in a dose-dependent manner without cytotoxicity. In addition, eriodictyol suppressed bone resorption activity of differentiated osteoclasts. The inhibitory effect of eriodictyol was associated with impaired activation of multiple signaling events downstream of RANK, including extracellular signal-regulated kinase, p38, and c-Jun terminal kinase phosphorylation, followed by decreased nuclear factor of activated T cells (NFAT)cl expression. Ectopic overexpression of a constitutively active form of NFATc1 completely rescued the anti-osteoclastogenic effect of eriodictyol, suggesting that the anti-osteoclastogenic effect was mainly attributed to the reduction in NFATc1 expression. Consistent with the in vitro anti-osteoclastogenic effect, eriodictyol suppressed lipopolysaccharide-induced osteoclast formation in the calvarial model and ovariectomy-induced bone loss in vivo. Taken together, our data demonstrate that eriodictyol is a new therapeutic agent with the potential to prevent bone destructive diseases by reducing both osteoclast differentiation and function. (C) 2015 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER INC | - |
dc.title | Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.yexcr.2015.10.001 | - |
dc.identifier.scopusid | 2-s2.0-84973410890 | - |
dc.identifier.wosid | 000366618700022 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL CELL RESEARCH, v.339, no.2, pp 380 - 388 | - |
dc.citation.title | EXPERIMENTAL CELL RESEARCH | - |
dc.citation.volume | 339 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 380 | - |
dc.citation.endPage | 388 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
dc.subject.keywordPlus | C-FOS | - |
dc.subject.keywordPlus | SIGNALING PATHWAY | - |
dc.subject.keywordPlus | KEY REGULATOR | - |
dc.subject.keywordPlus | NF-ATC | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | NFATC1 | - |
dc.subject.keywordPlus | RANKL | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | Eriodictyol | - |
dc.subject.keywordAuthor | Bone loss | - |
dc.subject.keywordAuthor | Osteoclast | - |
dc.subject.keywordAuthor | RANKL | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/abs/pii/S0014482715301075?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.